Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Uzbekistan launches €9.46 billion green energy push, covering nation’s power needs - 2Why the UAE has incurred the wrath of Somalia
- 3Ministry: New German petrol price regulation takes effect on April 1
- 4Pick Your Favored sort of cooking
- 5'Israel has the right to continue its attacks,' Lebanese Foreign Minister announces
- Benin coup thwarted by loyalist troops, president tells nation
- 6 Methods for further developing Rest Quality
- Former ‘Dancing with the Stars’ Pro Survives Plane Crash at LaGuardia That Left 2 Pilots Dead
- Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
- The 10 Most Noteworthy Games in History
- Vote In favor of Your Number one Game Control center
- How Skoda Lost Its Biggest Market In Just Seven Years
- This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- Audits of 6 Specialty Mixed drinks
